Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2008 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
N Engl J Med. 2004 Oct 7;351(15):1502-12. doi: 10.1056/NEJMoa040720.
N Engl J Med. 2004.
PMID: 15470213
Free article.
Clinical Trial.
Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa.
Berthold DR, Pond GR, de Wit R, Eisenberger M, Tannock IF; TAX 327 Investigators.
Berthold DR, et al.
Ann Oncol. 2008 Oct;19(10):1749-53. doi: 10.1093/annonc/mdn288. Epub 2008 May 16.
Ann Oncol. 2008.
PMID: 18487550
Free article.
Clinical Trial.
Item in Clipboard
Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study.
Berthold DR, Pond GR, Roessner M, de Wit R, Eisenberger M, Tannock AI; TAX-327 investigators.
Berthold DR, et al.
Clin Cancer Res. 2008 May 1;14(9):2763-7. doi: 10.1158/1078-0432.CCR-07-0944.
Clin Cancer Res. 2008.
PMID: 18451243
Clinical Trial.
Item in Clipboard
Cite
Cite